Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis

OBJECTIVES: Percutaneous radiofrequency ablation (RFA) is stated as a treatment option for renal cell carcinoma (RCC) smaller than 4 cm (T1a). Microwave ablation (MWA) is a newer technique and is still considered experimental in some guidelines. The objective of this study was to compare the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Aarts, Brigit M., Gomez, Fernando M., Lopez-Yurda, Marta, Bevers, Rob F. M., Herndriks, Joris, Beets-Tan, Regina G. H., Bex, Axel, Klompenhouwer, Elisabeth G., van der Meer, Rutger W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Interventional
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889465/
https://www.ncbi.nlm.nih.gov/pubmed/36066733
http://dx.doi.org/10.1007/s00330-022-09110-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889465/
https://www.ncbi.nlm.nih.gov/pubmed/36066733
http://dx.doi.org/10.1007/s00330-022-09110-w

Ejemplares similares